Abstract

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease

Author(s): McElhiney Linda F

Issue: May/Jun 2012 - Volume 16, Number 3

Page(s): 190-195

Download in electronic PDF format for $75

Abstract

Vital dyes have been used for over a hundred years to assist ophthalmic practitioners in diagnosing their patients’ problems. Patients don’t always tolerate the commercial products, usually due to the preservatives, and may need a compounded preparation. Some dyes are not commercially available, such as the brilliant blue G, and compounders who specialize in high-risk compounded sterile preparations are needed to meet these needs of the ophthalmologists. This article discusses some of these staining agents, including their properties.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Jul/Aug 2004 Pg. 277-283	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Author(s): Davidson Gigi S
May/Jun 2004 Pg. 169-172	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Author(s): Davidson Gigi S
Sep/Oct 2004 Pg. 359-367	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Author(s): Davidson Gigi S
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 411-414	Compounding for Feline Herpetic Keratitis Author(s): Davidson Gigi S
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 418-426	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 452-456	Cleaning of Isolators: A Vital Part of a Contamination Control Program Author(s): Rossington Karen
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Mar/Apr 2001 Pg. 92-94	Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Author(s): Davidson Michael G